The Science

The mechanism.

Your cells have a power problem. Red light fixes it.

Every cell in your body runs on ATP - adenosine triphosphate - the molecule your mitochondria produce to power every biological function. When cells are stressed, damaged, or ageing, an inhibitory molecule called nitric oxide (NO) blocks cytochrome c oxidase (CCO), the terminal enzyme in the mitochondrial electron transport chain. This blocks ATP production and accelerates cellular decline.

Red and near-infrared light, at specific wavelengths between 600nm and 1064nm, is absorbed directly by cytochrome c oxidase. The photons displace the inhibitory nitric oxide, restoring enzyme activity. The result: a surge in mitochondrial membrane potential, increased oxygen consumption, elevated ATP output, and a cascade of downstream repair and regeneration signals throughout the cell.

This is not a surface-level effect. It is a cellular energy intervention backed by hundreds of peer-reviewed studies across three decades of research.

CYTOCHROME C OXIDASE (CCO): The primary photoreceptor in the mitochondrial respiratory chain.
ATP: Adenosine triphosphate. The cellular energy currency.
PHOTOBIOMODULATION (PBM): The scientific name for therapeutic light at this dose.
THERAPEUTIC WINDOW: 460nm to 1064nm. The wavelength range where the response occurs.

Coherent light. Concentrated dose.

Not all light is equal. Not all red light devices are equal.

LED devices scatter light in all directions. When scattered, incoherent photons contact tissue, a significant portion is reflected at the skin surface and the remainder disperses as it travels through the dermal layers. The result: lower irradiance at the target tissue depth.

VCSEL laser technology - the technology inside the RX1 - produces coherent, monochromatic light. All photons travel in the same direction, at precisely the same wavelength. This dramatically reduces scatter and reflection, concentrating energy at the target tissue depth rather than dispersing it across the surface.

The practical consequence is irradiance. The RX1 operates at 83 to 95 mW/cm² - within the therapeutic window established in photobiomodulation research. Most LED masks on the market operate at 5 to 30 mW/cm², below the threshold required to trigger the cellular response the research documents.

	LED Masks	RX1 / VCSEL Laser
Light type	Incoherent, scattered	Coherent, focused
Irradiance	5-30 mW/cm²	83-95 mW/cm²
Penetration	Surface-level	2-15mm into tissue
Wavelength precision	Variable	Monochromatic, verified

Wavelength is the variable that matters.

Different wavelengths penetrate tissue to different depths and trigger different biological responses. This is not marketing - it is physics and biochemistry. The RX1 delivers four distinct wavelengths, each targeting a different depth and biological mechanism.

460NM

BLUE

The shortest wavelength in the RX1 system, blue light penetrates 1.2 to 1.5mm into the skin - precisely the depth of the sebaceous glands where acne-causing bacteria (Cutibacterium acnes) reside. At 460nm, light is absorbed by porphyrins, molecules naturally produced by C. acnes bacteria. This absorption generates reactive oxygen species that destroy the bacteria's cell wall and DNA. Clinical trials show blue light at this wavelength achieves bactericidal effects at doses as low as 5 J/cm², with studies demonstrating reductions in acne lesion count and inflammation. Blue light at 460nm also helps regulate sebum production, targeting one of the root causes of breakouts rather than the surface symptom.

665NM

DEEP RED

665nm sits within the most-studied band in photobiomodulation research for skin rejuvenation (660-670nm). Research demonstrates that wavelengths within this range are bioequivalent - producing near-identical biological effects due to overlapping absorption peaks. At 665nm, light penetrates 2 to 4mm into the dermis, reaching the fibroblast-rich reticular layer where collagen and elastin synthesis occurs. Clinical studies show this wavelength increases collagen density by up to 31% over 12 weeks of consistent use, reduces wrinkle depth, improves skin roughness, normalises pigmentation, and accelerates wound healing. A comparative study found 660-670nm light increased fibroblast proliferation by over 60% within 48 hours.

850NM

NEAR-INFRARED

Penetrates beyond the dermis into muscle, joint, and connective tissue - depths that red wavelengths cannot reach. 850nm triggers nitric oxide release in blood vessel walls, improving local microcirculation and nutrient delivery. It is the primary anti-inflammatory wavelength, directly reducing inflammatory cytokines at the site of chronic inflammation. A 2024 meta-analysis found 850nm-inclusive protocols reduced CRP and IL-6 (key inflammation markers) by up to 40% over four weeks. Primary wavelength for recovery, joint health, pain management, and any therapeutic application requiring penetration beyond the skin surface.

1064NM

DEEP INFRARED

The deepest-penetrating wavelength in the RX1 system. 1064nm is distinguished by minimal melanin absorption - meaning it passes through surface tissue without significant scatter or heat generation. At this wavelength, light reaches ligaments, tendons, bone surface, and the deepest layers of connective tissue. The mechanism is the same as shorter near-infrared wavelengths - cytochrome c oxidase activation, nitric oxide displacement, ATP production - but operating at a depth that 850nm cannot consistently reach. Research using 1064nm shows fibroblast proliferation, collagen synthesis, and tissue regeneration in dense structures that are typically difficult to treat non-invasively.

The RX1 operates across the full therapeutic spectrum - from surface antibacterial activity at 460nm to deep tissue regeneration at 1064nm.

What happens to your skin.

The facial skin evidence base is the strongest in photobiomodulation research. The mechanisms are well-understood, the outcomes are measurable, and the clinical trials go back over two decades.

Collagen and wrinkle reduction. A controlled trial published in PMC found that participants who received twice-weekly red and near-infrared light treatments over three months showed statistically significant improvements in skin texture, wrinkle depth, and intradermal collagen density confirmed via ultrasound measurement. A separate study of 76 subjects found 91% reported improved skin tone and 82% reported reduced wrinkle severity after 9 sessions.

Acne. A 2025 meta-analysis in JAMA Dermatology reviewed six studies and found at-home light therapy devices reduced acne lesions by approximately 45% over 4 to 8 weeks. A Korean randomised controlled trial found red and blue light combined reduced inflammatory acne by up to 77%.

Outcomes in clinical studies were achieved with consistent, protocol-adherent use over 4 to 12 weeks. Sporadic use does not reproduce clinical results.

91%

reported improved skin tone

Clinical study, 76 subjects
31%

collagen density increase

Over 12 weeks
77%

reduction in inflammatory acne

Randomised controlled trial
45%

acne lesion reduction

JAMA Dermatology meta-analysis, 2025

Beyond the surface.

When near-infrared light penetrates past the skin into muscle, joint, and connective tissue, the cellular energy effect scales with it. The research on systemic photobiomodulation benefits is extensive - and growing.

Inflammation: A 2024 meta-analysis found photobiomodulation reduced inflammatory markers including C-reactive protein (CRP) and interleukin-6 (IL-6) by up to 40% in controlled trials. CRP reduction averaged 38% over 4 weeks of consistent use.
Muscle recovery: A 2024 meta-analysis of 34 randomised controlled trials found pre-exercise photobiomodulation significantly improved muscle endurance and accelerated recovery of muscle strength and injury biomarkers in both athletes and sedentary populations. Athletes showed 45% less muscle soreness at 24 hours compared to placebo.
Pain reduction: A systematic review published in The Lancet found low-level light therapy significantly reduced pain and disability in chronic joint conditions. Research on low back pain, rotator cuff injury, and joint inflammation consistently shows statistically significant reductions in pain scores versus control.
Circulation: Near-infrared light triggers nitric oxide release in blood vessel walls - the same mechanism that prescription vasodilators use. This improves local microcirculation, nutrient delivery to tissue, and clearance of metabolic waste products.

The cellular energy mechanism that drives facial skin results is the same mechanism operating throughout the body. Photobiomodulation produces the same fundamental cellular response wherever sufficient irradiance reaches target tissue.

IRRADIANCE AT TARGET TISSUE

83-95mW/cm²

The reason most at-home devices do not deliver clinical results is not the concept - it is the dose.

Photobiomodulation research, including foundational work by Dr. Michael Hamblin at Harvard Medical School, has established a dose-response relationship. Too little irradiance: no meaningful cellular response. Too much: diminishing returns and potential oxidative stress. The therapeutic window is well-documented: 4 to 10 J/cm² at the target tissue level, delivered at sufficient irradiance.

Most LED masks on the market deliver irradiance of 5 to 30 mW/cm² at the skin surface. Below the threshold. The session feels like something is happening. The cells are not registering enough energy to trigger the biological cascade the research describes.

The RX1 operates at 83 to 95 mW/cm² - within the therapeutic window. Ten minutes. The dose the research specifies.

"Beneficial effects increase with dose up to a threshold, then plateau or reverse. Irradiance below the threshold means no therapeutic effect, regardless of session duration."
Dr. Michael Hamblin / Harvard Medical School

The research is settled. The question is the device.

Red light therapy works. The clinical evidence across thousands of peer-reviewed studies is not ambiguous. What determines whether a device delivers those results is the technology behind it and the dose it produces.

The RX1 was built around the research - not around what looks convincing in a product photo.

Shop the RX1